A carregar...
Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
BACKGROUND: Asthma is a highly prevalent chronic inflammatory airways disease, with a considerable impact on quality of life (QoL). To express the effects of asthma on patients’ subjective experience, patient-reported outcomes (PROs) represent an important instrument. The asthma QoL questionnaire (A...
Na minha lista:
| Publicado no: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492364/ https://ncbi.nlm.nih.gov/pubmed/31035904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619841350 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|